A controlled comparison of metiapine and chlorpromazine in chronic schizophrenia.
D000704:Analysis of Variance; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001794:Blood Pressure; D001835:Body Weight; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D004562:Electrocardiography; D006236:Handwriting; D006339:Heart Rate; D006801:Humans; D008297:Male; D010879:Piperazines / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D003987:Dibenzothiazepines; D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents; D002746:Chlorpromazine